PR
MET.PRB

Payden & Rygel’s METLIFE INC PFD SERIES B MET.PRB Stock Holding History

Payden & Rygel’s Portfolio MET.PRB Stock Details MET.PRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,200
Closed -$80K – 265
2013
Q4 		$80K Buy
+3,200
New +$79.4K 0.03% 132

Other funds holding MET.PRB

RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
FBB
Fulton Breakefield Broenniman Bethesda, Maryland $1.53B AUM 18.11% 1-Year Est. Return
BAM
Banta Asset Management Newport Beach, California $112M AUM
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
MCC
Mid Continent Capital Chicago, Illinois $1.54B AUM 0.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
ARMC
American Research & Management Company Marion, Massachusetts $362M AUM 8.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MC
Mathes Company New York $274M AUM 33.72% 1-Year Est. Return

Payden & Rygel's MET.PRB Position: Q1 2014 in Review

Payden & Rygel sold out of METLIFE INC PFD SERIES B (MET.PRB) in Q1 2014, closing a stake of 3,200 shares — an estimated $80K sold.

Payden & Rygel first reported a position in MET.PRB in Q4 2013 and held it in 1 quarter. The position peaked at $80K in Q4 2013. 17 funds tracked by Wall St. Rank hold MET.PRB as of Q1 2014.

  • Payden & Rygel reported no remaining METLIFE INC PFD SERIES B position as of Q1 2014 after selling out during the quarter.
  • Payden & Rygel sold 3,200 METLIFE INC PFD SERIES B shares in Q1 2014, an estimated $80K.
  • Payden & Rygel first reported a position in METLIFE INC PFD SERIES B in Q4 2013 and held it in 1 quarter.
  • Payden & Rygel's METLIFE INC PFD SERIES B position peaked at $80K in Q4 2013.
  • 17 funds tracked by Wall St. Rank held METLIFE INC PFD SERIES B as of Q1 2014.

Based on Payden & Rygel's 13F filing for Q1 2014, filed 9 May 2014.